Natalie Giannakopoulou holds a PhD in Microbiology and Immunology from McGill University with a thesis on understanding the mechanisms of bacterial virulence and pathogenesis. She has more than four years of experience in nonclinical toxicology program management and is experienced with all routes of administration (oral, intravenous, subcutaneous, diet, dermal, intravesicular, intrathecal, intraperitoneal, and inhalation) and with numerous animal species (mice, rats, minipigs, dogs, rabbits, and monkeys). In addition to having managed multiple acute and chronic IND- and NDA-enabling studies, Natalie is skilled in early research development assays and data analyses, including LC-MS/MS, flow cytometry, and ligand-binding assays.